What Nobody Tells You About Staying on Antidepressants Long-Term
Antidepressants save lives, and for many people with moderate to severe depression or anxiety, they’re the difference between functioning and not functioning. That’s the starting point for this article, not a caveat tacked on at the end. But the median American on an antidepressant has now been taking one for roughly five years, while the clinical trials that earned these medications FDA approval mostly lasted eight to twelve weeks. That’s a significant evidence gap, and it means a lot of what we know about long-term antidepressant use comes from real-world observation and mechanistic research rather than from the tidy randomized trials patients assume are backing every year of their prescription. As a psychiatrist, I think patients deserve to know what that longer-term picture actually looks like — not to scare anyone off medication that’s working, but so that staying on it is an informed choice, revisited periodically, rather than something that happens by default.
Sexual Dysfunction That Doesn’t Always Resolve
Most people know SSRIs can blunt libido or delay orgasm while they’re taking them. Fewer know that for a small subset of patients, those sexual side effects persist after the medication is stopped — a condition called post-SSRI sexual dysfunction, or PSSD, now formally recognized by the European Medicines Agency. One large retrospective study estimated the risk at roughly 1 in 216 patients treated with serotonergic antidepressants, alongside a separately elevated risk of erectile dysfunction during active treatment. That’s a low-frequency risk, not a common one — but it’s not zero, and it’s the kind of thing worth knowing about before you start a medication, not discovering years later when you assume you’ve simply “always been like this.”
Emotional Blunting
Many long-term SSRI users describe a flattened emotional range — less sadness, but also less joy, less excitement, a kind of muted quality to everything. This is distinct from depression relapse, and it isn’t just patients’ imagination. Researchers have reproduced this effect in healthy volunteers with no history of depression given SSRIs for just three weeks, which strongly suggests it’s a direct pharmacological effect rather than a leftover symptom of the illness being treated. If a patient tells me they “don’t feel like themselves” even though their mood has technically improved, I take that seriously as a distinct side effect worth addressing, not a sign the medication is failing.
COMPOSITE PATIENT VIGNETTE
“Marcus,” a 31-year-old on sertraline for six years, came in describing himself as “fine, just kind of gray.” He wasn’t depressed by any clinical measure — he was going to work, sleeping normally, no anhedonia in the classic sense. But he couldn’t remember the last time he’d felt genuinely excited about anything, including things he used to love. He’d assumed that was just adulthood. It was, in large part, six years of unaddressed emotional blunting.
When the Medication Seems to Stop Working: Tachyphylaxis and “Tardive Dysphoria”
Some patients do well on an antidepressant for a year or two and then find it gradually stops working — a phenomenon called antidepressant tachyphylaxis, sometimes informally called “poop-out.” A more provocative hypothesis, still debated in the research literature, is that prolonged antidepressant use at adequate doses can in some patients actively induce a treatment-resistant depressive state through the brain’s own adaptive changes, a proposed mechanism researchers have named “tardive dysphoria,” by analogy to tardive dyskinesia from long-term antipsychotic use. This isn’t settled science, and it shouldn’t be read as “antidepressants cause depression” in any simple sense. But it’s a serious enough hypothesis that if a patient’s depression seems to be creeping back after years of stability on the same medication and dose, the answer isn’t automatically “increase the dose” — it may be worth reassessing the whole treatment plan.
RESEARCH NOTE
The median duration of antidepressant use in the United States is approximately five years, while the placebo-controlled trials supporting these medications typically last eight to twelve weeks — one of the more significant evidence gaps in modern prescribing. Much of what’s understood about years-long use comes from observational data and mechanistic research rather than long-duration randomized trials.
Withdrawal, Bleeding Risk, and a Few Other Things Worth Knowing
A few additional risks are worth flagging briefly. Discontinuation syndrome — dizziness, “brain zaps,” irritability, flu-like symptoms — is more common and can last longer than most people expect, especially with shorter-half-life medications, which is why stopping should almost always be a planned taper rather than an abrupt stop. SSRIs also deplete serotonin from platelets, which modestly raises gastrointestinal bleeding risk, particularly when combined with NSAIDs like ibuprofen or with blood thinners. In older adults, long-term use has been linked to low sodium levels (hyponatremia) and to reduced bone density with a corresponding increase in fracture risk, both of which are reasonable to monitor for with periodic labs and a conversation about bone health in patients on antidepressants for many years.
What I’d Actually Want Patients to Take From This
None of this is a reason to stop a medication that’s working, and untreated depression or anxiety carries real risks of its own that are often more severe than any of the side effects above. But “working” deserves periodic reassessment rather than being assumed indefinitely. If you’ve been on the same antidepressant for years, it’s worth asking your prescriber directly: is this still the right medication and dose, are there sexual or emotional side effects I haven’t mentioned because I assumed they were just me, and is there a plan for reassessing this periodically rather than renewing it by default. Good long-term psychiatric care treats a prescription as a decision to keep revisiting, not a decision made once and left alone.
On an antidepressant and not sure if it’s still right for you?
Dr. Mark Agresti provides integrative psychiatric care for young adults in Palm Beach and throughout Florida via telemedicine, with a focus on thoughtful, periodic medication reassessment rather than indefinite prescribing on autopilot.
44 Cocoanut Row, Suite M202, Palm Beach, FL 33480 | [(561) 760-4107](tel:(561) 760-4107) | [email protected] | DrMarkAgresti.com